´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ IGET Symposium 2020 / Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-24±³À°ÀÏÀÚ : 2020-07-24
±³À°Àå¼Ò : ¿ÀÇÁ¶óÀÎ & ¿Â¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B)
±³À°ÁÖÁ¦ :
IGET Symposium 2020 / Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ :
office@intervention.or.kr ±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í ¿Â¶óÀÎ: »çÀüµî·Ï 10000¿ø / ¿ÀÇÁ¶óÀÎ-»çÀüµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø / ¿ÀÇÁ¶óÀÎ-ÇöÀåµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:00~09:05 IGET Symposium Opening Remark ()
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:05~09:20 My strategy of endovascular management for chronic dissection ¹ÌÁ¤(¹ÌÁ¤)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:20~09:35 Long term durability of EVAR : Where do we stand? °Ã¤ÈÆ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:35~09:50 Tips and tricks of hostile neck for EVAR Çöµ¿È£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:50~10:05 Endovascular management of iliac aneurysm Àü¿ë¼±(ÀÎÇÏÀÇ´ë)
Åä·Ð 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:05~10:20 Discussion ±èâ¿ø(ºÎ»êÀÇ´ë)
ÈÞ½Ä 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:20~10:30 Coffee break ()
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:30~10:45 Recent update of Endovascular treatment of complex aortoiliac disease À̸í¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:45~11:00 Latest results of stents in Femoropopliteal disease Á¶¼ö¹ü(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:00~11:15 Endovascular treatment for femoropopliteal disease by DCB – Korea experience ±èÁø¿ì(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:15~11:30 Latest information of Paclitaxel safety ½Éµ¿Àç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:30~11:45 What is the best options (POBA, DCB or DES) for BTK interventions? ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë)
Åä·Ð 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:45~11:55 Discussion ¿øÁ¦È¯(¾ÆÁÖÀÇ´ë)
±âŸ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:55~12:00 IGET Symposium Closing Remark ()
½Ä»ç 07-24 12:00~12:55 ½Ä»ç ()
±âŸ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 12:55~13:00 Á¦29Â÷ Á¤±âÇмú´ëȸ Opening Remark ()
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:00~13:10 The impact of socioeconomic status on mortality in initial TACE candidates for HCC: A Korean national cohort study ¾ç¿ìÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:10~13:20 Effectiveness of Adding Delayed-phase Cone-beam Computed Tomography for Hepatocellular Carcinomas Dectectability and Treatment ±è¼¿µ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:20~13:30 Fluoroscopy-guided Double J urinary stent exchange via transurethral access in Male and Female patients °ûÁ¤¿ø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:30~13:40 Lymphatic Embolization versus Sclerotherapy for Symptomatic Post-operative Pelvic Lymphocele (LESPOL): A Randomized Pilot Study ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:40~13:50 Plug assisted retrograde trasvenous lymphatic embolization(PARLE) for thoracic duct embolization in chylothorax patient ±ÇÈÆ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:50~14:00 Percutaneous lymphatic intervention for the treatment of postoperative lymphatic ascites related to pelvic surgery: analysis of factors affecting outcome ÀÌ°æ¹Î(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:00~14:15 Procedure-related emergency ¼Û¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:15~14:30 Periprocedural Management of Coagulation Status & Hemostasis Risk in Interventional Procedures ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:30~14:45 Pain control / sedation ±è¸¸µæ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:45~15:00 Surgical perspective ³ë½Â¿¬(°æÈñÀÇ´ë)
Åä·Ð 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:00~15:10 Discussion Àü¿õ¹è ±èÇü¿í(ºÎ»êÀÇ´ë Àü³²ÀÇ´ë)
ÈÞ½Ä 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:10~15:30 Coffee break ()
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:30~16:00 Diagnostic reference level in IR À̸í¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:00~16:10 Plug-assisted retrograde transvenous obliteration (PARTO) for duodenal varix via the right gonadal vein ¾ç¿ìÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:10~16:20 Importance of pedal muscular branch in transcollateral pedal angioplasty ±èÁ¤Àº(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:20~16:30 Amazing response of advanced HCC with intra-arterial chemotherapy ±è¼ºÈ£(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:30~16:40 Transcatheter arterial embolization for chronic non-specific back pain (lumbar pain) ÀÌ»óȯ(¾çÁöº´¿ø)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:40~16:50 lymphovenous microsurgery for intractable chylous ascites : role of intraoperative lymphangiography Á¤À±¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 16:50~17:00 Percutaneous sclerotherapy for large thoracoabdominal lymphatic cyst ½ÅÁöÈÆ(¿ï»êÀÇ´ë)
Åä·Ð 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 17:00~17:10 Discussion ÀÌ¿õÈñ °¿õ·¡(¼øõÇâÀÇ´ë ´ë±¸°¡Å縯´ëÇб³º´¿ø)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 17:10~17:20 Cook Medical ÀÌ¿ì¶÷(Cook Medical)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 17:20~17:30 ¢ß¼¼¸íMD ÃÖÁø´ö(¢ß¼¼¸íMD)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 17:30~17:40 Boston Scientific ÀÌÀºÁÖ(Boston Scientific)
±³À°½Ã°£ 07-24 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 17:40~17:50 Philips ±è½ÅÈ£(Philips)